Sistema de Información Esencial en Terapéutica y Salud

@SIETES7

Última actualización: 30/3/2020
SIETES contiene 92954 citas

 
 
<< anterior 21 a 30 de 30 
Presentar resultados
Seleccionar todas
21. Cita con resumen
22.Tiene citas relacionadas
Havlir DV. HIV integrase inhibitors - Out of the pipeline and into the clinic. N Engl J Med 2008;359:416-8. [Ref.ID 83714]
23.Tiene citas relacionadas
Cooper DA, Steigbigel RT, Gatell JM, Rockstroh JK, Katlama C, Yeni P, Lazzarín A, Clotet B, Kumar PN, Eron JE, Schechter M, Markowitz M, Loutfy MR, Lennox JL, Zhao J, Chen J, Ryan DM, Rhodes RR, Killar JA, Gilde LR, Strohmaier KM, Meibohm AR, Miller MD, Hazuda DJ, Nessly ML, DiNubile MJ, Isaacs RD, Teppler H, Nguyen B-Y, for the BENCHMRK Study Teams. Subgroup and resistance analyses of raltegravir for resistant HIV-1 infection. N Engl J Med 2008;359:355-65. [Ref.ID 83712]
24.Tiene citas relacionadas
Steigbigel RT, Cooper DA, Kumar PN, Eron JE, Schechter M, Markowitz M, Loutfy MR, Lennox JL, Gatell JM, Rockstroh JK, Katlama C, Yeni P, Lazzarín A, Clotet B, Zhao J, Chen J, Ryan DM, Rhodes RR, Killar JA, Gilde LR, Strohmaier KM, Meibohm AR, Miller MD, Hazuda DJ, Nessly ML, DiNubile MJ, Isaacs RD, Nguyen B-Y, Teppler H, for the BENCHMRK Study Teams. Raltegravir with optimized background therapy for resistant HIV-1 infection. N Engl J Med 2008;359:339-54. [Ref.ID 83711]
25. Cita con resumen
26. Cita con resumen
Anónimo. Two new drugs for HIV infection. Med Lett Drugs Ther 2008;50:2-4. [Ref.ID 82088]
27. Cita con resumen
Charlish P. Product problems plague industry. Scrip 100 2007:S54-7. [Ref.ID 82028]
28.Tiene citas relacionadas Cita con resumen
Hirschel B, Perneger T. No patient left behind - better treatments for resistant HIV infection. Lancet 2007;370:3-5. [Ref.ID 80485]
29.Tiene citas relacionadas Cita con resumen
Grinsztejn B, Nguyen B-Y, Katlama C, Gatell JM, Lazzarín A, Vittecoq D, González CJ, Chen J, Harvey CM, Isaacs RD, for the Protocol 005 Team. Safety and efficacy of the HIV-1 integrase inhibitor raltegravir (MK-0518) in treatment-experienced patients with multidrug-resistant virus: a phase II randomised controlled trial. Lancet 2007;369:1261-9. [Ref.ID 79785]
30.Tiene citas relacionadas Cita con resumen
Cahn P, Sued O. Raltegravir: a new antiretroviral class for salvage therapy. Lancet 2007;369:1235-6. [Ref.ID 79778]
Seleccionar todas
 
<< anterior 21 a 30 de 30